Clinical Chemistry II

Course Description

Clinical Chemistry II covers basic chemistry functions including kidney function, blood gases, and pancreatic function assessment. It also includes the more esoteric tests involved in testing endocrine function, therapeutic drug monitoring, toxicology, tumor markers, and testing during pregnancy. Methodology is primarily immunoassay, potentiometry and spectrophotometry. UWF notes that permission is required and that MLS students are required to take the corresponding laboratory, MLS4630L, as a co-requisite.

Within the SCNS taxonomy, MLS is the Medical Laboratory Sciences prefix. The University of West Florida publishes this at 2 semester hours through the Department of Medical Laboratory Sciences, College of Health. It is offered at approximately 4 Florida institutions.

⚠ This is the second half of a split subject. UWF runs clinical chemistry as MLS4625 and MLS4630 at 2 semester hours each, with separate laboratories, followed by the hospital rotation MLS4820L. A student transferring needs the whole set to match a single larger clinical chemistry course elsewhere — carry a syllabus.

Where Clinical Chemistry I centred on two very common questions, this course covers the long tail — and the long tail is where interpretation gets hard. Kidney function and blood gases are high-volume and physiologically demanding; endocrine testing involves hormones that vary with time of day, feedback loops, and binding proteins; therapeutic drug monitoring depends on when the specimen was drawn relative to the dose. The recurring theme is that these results cannot be read without knowing the circumstances of collection, which is a different skill from the analytical accuracy of the first course.

⚠⚠ UWF runs TWO parallel MLS tracks — check which sequence you are in

• UWF publishes two distinct routes through the same subject matter. One is a split lecture-plus-laboratory sequence (for example MLS4550 with MLS4550L, MLS4625 with MLS4625L), whose prerequisites are general science courses such as PCB3063 and BCH3033. The other is a "Professional Track" of integrated 3- and 4-credit C-suffix courses (MLS4193C, MLS4221C, MLS4306C, MLS4335C, MLS4461C, MLS4463C, MLS4506C, MLS4552C, MLS4626C, MLS4631C), whose prerequisites are the MLS-internal MLS3194 and MLS3621.
• ⚠ The two tracks are not interchangeable and their prerequisites differ. A student entering through general science prerequisites lands in the split sequence; one already inside the MLS programme lands in the Professional Track.
• ⚠⚠ This is not the usual C-suffix meaning. Elsewhere in Florida, a C suffix marks an integrated lecture-plus-laboratory version of the same course. At UWF in this prefix it marks a different programme track, with different entry requirements — so reading the suffix by the statewide convention will mislead.
• Confirm with the department which sequence your programme requires before enrolling in either.

⚠ The contact-hour figure is derived — the University of West Florida publishes none

UWF's catalog publishes a credit value in semester hours, the college and department, prerequisites, co-requisites, fee notices, and a description. It does not publish contact hours, a lecture and laboratory split, or terms of offering for any course. Every contact-hour value in a UWF guide in this repository is therefore derived. The figure here applies the standard lecture convention of 15 contact hours per credit, giving 30 hours for a 2-semester-hour course. Confirm the meeting schedule with the department.

Learning Outcomes

Required Outcomes

• Describe renal physiology and the basis of kidney function testing.
• Describe creatinine, urea, and estimated glomerular filtration rate.
• Interpret markers of kidney injury and chronic kidney disease staging.
• Describe electrolyte physiology and measurement.
• Calculate and interpret the anion gap and osmolal gap.
• Describe acid-base physiology and buffering systems.
• Interpret arterial blood gas results and classify acid-base disorders.
• Recognise compensation and mixed acid-base disturbances.
• Describe pancreatic function and its laboratory assessment.
• Describe amylase and lipase in the diagnosis of pancreatitis.
• Describe liver function tests and patterns of hepatic injury.
• Describe endocrine feedback axes and their laboratory evaluation.
• Describe thyroid function testing and interpret common patterns.
• Describe adrenal and pituitary function testing including dynamic tests.
• Describe therapeutic drug monitoring and the significance of peak and trough.
• Describe pharmacokinetic principles relevant to drug monitoring.
• Describe toxicology screening and confirmatory testing.
• Describe common poisonings and their laboratory findings.
• Describe tumour markers and their appropriate clinical use.
• Describe laboratory testing in pregnancy including maternal screening.
• Select appropriate methodology for a given analyte.

Optional Outcomes

• Describe mass spectrometry in toxicology and endocrinology.
• Describe newborn screening programmes.
• Describe vitamin and trace element testing.
• Describe bone turnover markers.
• Describe cerebrospinal and other body fluid chemistry.
• Describe pharmacogenomics in drug dosing.

Major Topics

Required Topics

• Renal physiology and function testing
• Creatinine, urea, and eGFR
• Kidney injury and CKD staging
• Electrolytes and their measurement
• Anion gap and osmolal gap
• Acid-base physiology
• Blood gas interpretation
• Compensation and mixed disorders
• Pancreatic function; amylase and lipase
• Liver function tests and injury patterns
• Endocrine feedback axes
• Thyroid function testing
• Adrenal and pituitary testing
• Therapeutic drug monitoring
• Pharmacokinetics; peak and trough
• Toxicology screening and confirmation
• Common poisonings
• Tumour markers
• Testing in pregnancy
• Methodology selection

Optional Topics

• Mass spectrometry applications
• Newborn screening
• Vitamins and trace elements
• Bone turnover markers
• Body fluid chemistry
• Pharmacogenomics

Resources & Tools

• Bishop, Fody and Schoeff — the standard text, continuing from MLS4625.
• Tietz — the reference work; particularly strong on endocrine and toxicology methods.
• KDIGO guidelines (kdigo.org) — free; the international standard for chronic kidney disease staging and the basis of how eGFR is reported.
• An acid-base practice tool — several are free; blood gas interpretation is a pattern-recognition skill built by working many cases, and doing fifty of them is worth more than reading the chapter twice.
• American Thyroid Association guidelines — free; thyroid testing algorithms and the reasoning behind reflex testing.
• NIDA and SAMHSA drug testing guidance — free; cutoffs, screening versus confirmation, and chain of custody.
• ASCO tumour marker guidelines — free; they are notably restrained about what markers should and should not be used for, which is the point.
• ASCP Board of Certification content guideline — free.

Career Pathways

• Medical and clinical laboratory technologists and technicians — SOC 29-2011 and 29-2012; a persistent national shortage occupation, and hospital laboratories recruit continuously.
• Florida hospital systems — AdventHealth, Orlando Health, BayCare, Baptist Health, Tampa General, Jackson Health, and in UWF's own region Baptist Health Care and Ascension Sacred Heart in Pensacola.
• Reference and commercial laboratories — Quest Diagnostics and Labcorp both operate substantial Florida facilities.
• Blood centres and transfusion services — OneBlood is the major Florida blood supplier.
• Public health laboratories — the Florida Department of Health Bureau of Public Health Laboratories, which handles outbreak and reportable-disease testing.
• Molecular and genetic testing laboratories — the fastest-growing segment of the field.
• Laboratory management and supervision — SOC 11-9111 adjacent; a normal progression after several years at the bench.
• In vitro diagnostics industry — applications, technical support, and field service roles with instrument and reagent manufacturers, which typically pay more than bench work.
• Pathway to further study — medical school, physician assistant, pathology assistant, and graduate work in molecular biology or public health.
• ⚠ An honest note on the work itself. Clinical laboratory scientists are largely invisible to patients and produce the majority of the objective data on which diagnoses are made. The work is shift-based, includes nights and weekends in hospital settings, and carries real consequence — a transfusion or a critical result acted on incorrectly harms someone.

Special Information

⚠⚠ Florida licenses clinical laboratory personnel — and most states do not

• Florida is one of a small number of states that require a state licence to work as clinical laboratory personnel. Licensure is administered by the Florida Department of Health, and a national certification alone is not sufficient to practise in Florida.
• ⚠ This is the single most important regulatory fact for a Florida MLS student, and it cuts both ways: graduates of a Florida programme are prepared for it, while someone certified in a non-licensure state who moves to Florida must obtain the state licence separately.
• The usual national credential is the ASCP Board of Certification MLS credential, earned by examination after completing a programme accredited by NAACLS.
• ⚠⚠ Programmatic accreditation matters more here than institutional accreditation. Eligibility to sit the certification examination generally depends on graduating from a NAACLS-accredited programme — so confirm a programme's current accreditation status directly with NAACLS before enrolling, and be careful about assuming that transferred coursework preserves eligibility.
• Laboratory testing itself is federally regulated under CLIA, which sets personnel requirements by test complexity — the framework within which both licensure and certification sit.

⚠⚠ "Permission is required" — this course is gated on programme admission

• UWF marks this course Permission is required, and the same phrase appears on nearly every course in the MLS prefix. Meeting the listed prerequisites does not make a student eligible to enrol.
• ⚠ In practice this means admission to the Medical Laboratory Sciences programme. Clinical laboratory science programmes are cohort-based and capacity-limited, because laboratory seats and clinical placements are finite — so admission is competitive and separate from admission to the university.
• ⚠⚠ Apply to the programme early and treat its deadlines as the real constraint. A student who completes every science prerequisite and misses the cohort application waits a full year, because a cohort sequence normally starts once a year — and UWF publishes no terms of offering, so this cannot be confirmed from the catalog.
• Contact the Department of Medical Laboratory Sciences, College of Health, before planning a schedule around these courses.

⚠⚠ MLS4630 and MLS4630L are taken together

• UWF states in the description that "MLS students are required to take the corresponding laboratory, MLS4630L, as a co-requisite." This is stated in prose rather than in a co-requisite field — and the corresponding laboratory carries the formal field in return.
• ⚠⚠ Note the conditional: the requirement is stated for MLS students. A student from another programme taking this course as an elective may not be bound by it — which also means they would get the didactic content without the bench work. Confirm with the department which applies to you.
• ⚠ UWF expresses co-requisites three different ways across its catalog — an explicit Co-requisite: field, an asterisk on a prerequisite meaning may be taken prior to or during the same term, and plain prose in the description. A reader who learns only one notation will misread the others.
• Budget for the pair. The lecture and laboratory are separate enrolments with separate credit, and the laboratory carries its own fees.

⚠⚠ These results cannot be interpreted without the circumstances of collection

• Therapeutic drug monitoring is meaningless without the timing. A trough drawn an hour after a dose is not a trough, and a result reported without the collection time relative to dosing invites a wrong dose adjustment.
• ⚠⚠ Blood gas specimens are uniquely fragile. Air bubbles alter oxygen and pH, delay changes results through continued cell metabolism, and a venous specimen labelled arterial produces a picture that looks like respiratory failure in a well patient.
• ⚠ Many hormones vary with time of day. Cortisol has a strong diurnal rhythm, so a random value is uninterpretable without knowing when it was drawn.
• Dynamic function tests depend on protocol adherence — suppression and stimulation tests are only interpretable if the timed specimens were actually collected on time.
• Binding proteins confound total hormone measurement. Pregnancy and oestrogen therapy raise thyroid binding globulin, which raises total thyroxine in a euthyroid person — which is why free hormone measurement largely replaced total.

⚠⚠ Tumour markers are the most misused tests in this course

• Most tumour markers are unsuitable for screening asymptomatic people, because their specificity is too low for the prevalence — the same predictive-value arithmetic that governs serology applies here and is ignored more often.
• ⚠ Their validated use is monitoring known disease — tracking response to treatment and detecting recurrence — where the patient serves as their own baseline.
• ⚠⚠ Benign conditions raise many tumour markers, and a raised result in a person without cancer triggers investigation, cost, and fear.
• Method changes break serial comparison. Marker values from different platforms are not interchangeable, so monitoring must stay on one method or the trend is an artefact.
• The hook effect gives falsely low results at very high concentration in some immunoassays — the analytical counterpart of the prozone effect, and a genuine trap.

⚠ Toxicology results carry legal weight

• Screening and confirmation are different tests with different purposes. Immunoassay screens are sensitive and cross-react; a positive screen is presumptive and requires confirmation, usually by mass spectrometry.
• ⚠⚠ Reporting an unconfirmed screen as a positive drug result can cost someone their job or their custody of a child. This is a real professional obligation, not a technicality.
• Chain of custody applies to forensic and workplace testing, and the documentation requirements are legal rather than clinical.
• Clinical and forensic toxicology have different standards, and a clinical result is generally not admissible as a forensic one.

⚠⚠ Where clinical chemistry results go wrong before the analyser sees them

• Haemolysis is the commonest interference and it is directional. Ruptured red cells release potassium and enzymes into the plasma, so a haemolysed specimen reports a falsely high potassium — and a falsely high potassium prompts urgent clinical action on a patient who does not have one.
• ⚠ Lipaemia and icterus interfere optically with spectrophotometric methods, and the direction of the error depends on the method.
• ⚠⚠ Specimen from above an infusion site is the classic catastrophic error — a glucose of several hundred with a diluted everything-else is the drip, not the patient.
• Delayed separation falls glucose, because cells keep consuming it; potassium rises in the opposite direction for the same reason.
• Order of draw and tube additive carryover alter results, and EDTA contamination of a chemistry tube produces a spectacular low calcium with a high potassium.
• ⚠ Delta checks and critical value protocols exist to catch these. A result wildly different from the patient's previous one is more often a specimen problem than a clinical event — investigate before reporting.

⚠⚠ Bloodborne pathogen exposure is a real occupational risk, and the controls are not optional

• Clinical laboratory work involves human blood and body fluids, which are treated as infectious regardless of the patient's known status. That is Standard Precautions, and it is the organising rule of laboratory practice.
• The OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030) is law, not guidance — it requires an exposure control plan, personal protective equipment, engineering controls, and hepatitis B vaccination offered at no cost.
• ⚠⚠ Needlestick and sharps injuries are the highest-risk exposure route. Never recap needles by hand, dispose of sharps at the point of use, and report every exposure immediately — post-exposure prophylaxis is time-critical, and the instinct to say nothing is the dangerous one.
• Aerosol generation is the underestimated route. Uncapping tubes, centrifuge accidents, and pipetting all generate aerosols; a centrifuge that is unbalanced or opened too early is a genuine hazard.
• ⚠ Programmes normally require immunisation records, a health screening, and sometimes a background check and drug screen before clinical placement. Start these early — they take longer than students expect and can delay a placement.
• Chemical hazards sit alongside the biological ones, and both belong in the same safety habit.

⚠⚠ Quality control is the discipline, not a chore attached to it

• A result is worthless without evidence that the method was performing when it was produced. That evidence is quality control, and in clinical laboratory science it is the professional skill rather than an administrative overhead.
• ⚠ Learn Levey-Jennings charts and the Westgard rules properly. They are how a laboratory distinguishes normal analytical variation from a real shift or trend, and they are examined on the ASCP board certification.
• ⚠⚠ The consequence of releasing a result from an out-of-control run is a patient managed on a wrong number. Delta checks, critical value protocols, and result verification exist because that happens and because it harms people.
• Pre-analytical error dominates. Most laboratory errors occur before the specimen reaches the analyser — wrong patient, wrong tube, haemolysis, insufficient volume, wrong order of draw — and the laboratory is frequently blamed for errors that happened at collection.
• Accuracy, precision, sensitivity, specificity and predictive value are used precisely here, not loosely. Predictive value depends on disease prevalence, which is why the same test performs differently in different populations.

Course format and position in the curriculum

• Lecture with examinations, taken with MLS4630L for MLS majors.
• Typically taken after MLS4625 within the cohort sequence.
• ⚠ Acid-base is the unit students most often struggle with, and it rewards systematic method over intuition — work through a fixed sequence every time rather than pattern-matching.
• Followed by the hospital rotation MLS4820L Clinical Chemistry III.
• UWF publishes no contact hours, lecture and laboratory split, or terms of offering for any course, and no fee notice appears on this entry. Confirm the offering pattern with the department.

How Florida course levels affect transfer

The first digit of an SCNS number denotes the year of offering, not transferability. Courses at the 1000 and 2000 levels transfer transparently between Florida public institutions, and 3000 to 4000 is unproblematic since both are upper division. The boundary that actually matters is 2000 to 3000, where lower-division credit generally cannot satisfy an upper-division requirement. ⚠ For clinical laboratory sciences the more important constraint is programmatic rather than numeric: courses are gated on admission to a cohort, sequenced tightly, and tied to NAACLS accreditation and to eligibility for certification — so transferring individual courses between programmes is frequently not possible even where the credit itself articulates.

MLS4630 is 2 semester hours at the University of West Florida, taken with the 1-semester-hour MLS4630L by MLS majors.